Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation
Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Methods Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from para...
Saved in:
Published in | Journal of international medical research Vol. 42; no. 5; pp. 1110 - 1117 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.10.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations.
Methods
Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid.
Results
EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE.
Conclusions
There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE. |
---|---|
AbstractList | Objective
A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations.
Methods
Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid.
Results
EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE.
Conclusions
There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE. OBJECTIVEA retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations.METHODSPretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid.RESULTSEGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE.CONCLUSIONSThere was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE. A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid. EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE. There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE. Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Methods Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid. Results EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE. Conclusions There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE. |
Author | Zou, JianYong Han, XiangQian Su, ChunHua Bella, Amos Ela Chen, ZhenGuang Luo, HongHe Lei, YiYan |
Author_xml | – sequence: 1 givenname: JianYong surname: Zou fullname: Zou, JianYong – sequence: 2 givenname: Amos Ela surname: Bella fullname: Bella, Amos Ela – sequence: 3 givenname: ZhenGuang surname: Chen fullname: Chen, ZhenGuang – sequence: 4 givenname: XiangQian surname: Han fullname: Han, XiangQian – sequence: 5 givenname: ChunHua surname: Su fullname: Su, ChunHua – sequence: 6 givenname: YiYan surname: Lei fullname: Lei, YiYan – sequence: 7 givenname: HongHe surname: Luo fullname: Luo, HongHe |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25239875$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU9rFTEUxYNU7Gvr3pVk6Wb0Jpl_cSelrxYKhWLXQya5M03JJM9koryP4rc1z1cFBVeBe8_5hXvOGTnxwSMhbxi8Z6zrPoAAgBYaVjdC8k68IBtWd6LiZX5CNod1ddifkrOUngBq3jb8FTnlDRey75oN-bGN-DWj13saJnp1vb2nS17VaoNP1Hrqsp-pMuiDVlFbHxZFv9v1kS7K2dkrv9KdwxyVozhNORXfR3qz7JzVvyAHqlZeY6SjDS7MZe7oiI_qmw050ohzdmpFQ8f9399fkJeTcglfP7_n5GF79eXyc3V7d31z-em20kJ0a8XMyLRkBjrgU9-DbMdGCy6MQi6aEgtAXzMxStmLVo7Qg55AMyPaCTtjenFO3h25uxhKEmkdFps0Oqc8hpwG1rRCyrrwixSOUh1DShGnYRftouJ-YDAcChn-LaRY3j7T87ig-WP43UARVEdBUjMOTyUTX679P_AnlS2V_w |
CitedBy_id | crossref_primary_10_1111_1759_7714_15210 crossref_primary_10_1097_MCP_0000000000000264 crossref_primary_10_18632_oncotarget_23686 crossref_primary_10_1007_s13665_018_0196_1 crossref_primary_10_1002_cam4_2458 crossref_primary_10_5761_atcs_oa_17_00088 crossref_primary_10_1016_j_jmoldx_2017_10_007 crossref_primary_10_3892_ol_2017_7195 crossref_primary_10_1177_2373997515616584 crossref_primary_10_1038_srep13574 crossref_primary_10_2217_fon_2016_0163 crossref_primary_10_1007_s12672_024_01094_x crossref_primary_10_1186_s12885_022_09701_2 crossref_primary_10_1093_ejcts_ezaa394 |
Cites_doi | 10.1146/annurev.me.41.020190.000255 10.1016/j.rmr.2011.03.005 10.1016/j.cell.2012.08.029 10.1183/09031936.00069812 10.1016/j.lungcan.2007.09.024 10.1183/09031936.00167407 10.1634/theoncologist.2011-0385 10.1378/chest.103.4_Supplement.385S 10.1097/JTO.0b013e31827ed0ff 10.1016/j.cllc.2011.02.006 10.1016/j.lungcan.2013.11.021 10.1016/j.ccm.2011.09.001 10.1097/JTO.0b013e318267223a 10.1038/nrclinonc.2011.126 10.1097/JTO.0b013e318168be93 10.1016/S0025-6196(11)60848-3 10.1016/j.lungcan.2010.12.009 10.1038/sj.bjc.6602296 10.1038/modpathol.2011.46 10.1016/j.lungcan.2007.02.016 10.1159/000338169 10.1016/0959-8049(95)00664-8 10.1200/JCO.2005.09.985 10.1007/s13402-012-0078-4 10.3322/caac.20107 10.3892/etm.2011.273 |
ContentType | Journal Article |
Copyright | The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav. |
Copyright_xml | – notice: The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav – notice: The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav. |
DBID | AFRWT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1177/0300060514539273 |
DatabaseName | Sage Journals GOLD Open Access 2024 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: AFRWT name: Sage Journals GOLD Open Access 2024 url: http://journals.sagepub.com/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1473-2300 |
EndPage | 1117 |
ExternalDocumentID | 10_1177_0300060514539273 25239875 10.1177_0300060514539273 |
Genre | Clinical Trial Journal Article |
GroupedDBID | --- .55 .GJ 01A 0R~ 29K 2WC 44B 53G 54M 5GY 5RE 5VS 7X7 8FI 8FJ AABQO AACKU AAGGD AAJIQ AAJOX AAJPV AAJQC AAMGE AANSI AAPEO AAQQG AAQXH AATBZ AAXOT AAYTG AAZBJ ABAFQ ABAWP ABDWY ABHKI ABJNI ABNCE ABPGX ABQKF ABQXT ABUWG ABVFX ABXGC ABYTW ACARO ACFMA ACFYK ACGBL ACGFS ACGZU ACLHI ACROE ACSIQ ACUIR ADBBV ADEIA ADMPF ADOGD ADQSQ ADTBJ ADUKL AECVZ AEDTQ AEFTW AEKYL AENEX AERKM AEUHG AEUIJ AEWDL AEWHI AEXFG AFCOW AFKBI AFKRA AFKRG AFRWT AIGRN AIOMO AJABX AJEFB AJMMQ AJSCY AJUZI ALIPV ALJHS ALMA_UNASSIGNED_HOLDINGS AOIJS AUTPY AYAKG BAWUL BCNDV BDDNI BENPR BFDSU BPHCQ BSEHC BVXVI CBRKF CCPQU CORYS CQQTX CUTAK D-I DC. DF. DF0 DIK DO- DV7 E3Z EBD EBS EF0 EJD EMOBN F5P FYUFA GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HMCUK HYE J8X JCYGO K.F KQ8 L7B MK0 O9- OK1 P2P PIMPY PQQKQ Q1R ROL RPM S01 SFC SV3 TR2 TUS UKHRP X7M ZE2 ZGI CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c337t-1db1c91d0702f88096b5c323dae235539008413b998369b080cf0c1d36fe7dd83 |
IEDL.DBID | AFRWT |
ISSN | 0300-0605 |
IngestDate | Fri Jun 28 10:51:54 EDT 2024 Wed Sep 11 13:45:10 EDT 2024 Sat Sep 28 08:15:37 EDT 2024 Tue Jul 16 20:39:17 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | EGFR mutation malignant pleural effusion Lung adenocarcinoma |
Language | English |
License | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm). The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c337t-1db1c91d0702f88096b5c323dae235539008413b998369b080cf0c1d36fe7dd83 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://journals.sagepub.com/doi/full/10.1177/0300060514539273?utm_source=summon&utm_medium=discovery-provider |
PMID | 25239875 |
PQID | 1563994070 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1563994070 crossref_primary_10_1177_0300060514539273 pubmed_primary_25239875 sage_journals_10_1177_0300060514539273 |
PublicationCentury | 2000 |
PublicationDate | 20141000 2014-Oct 2014-10-00 20141001 |
PublicationDateYYYYMMDD | 2014-10-01 |
PublicationDate_xml | – month: 10 year: 2014 text: 20141000 |
PublicationDecade | 2010 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: England |
PublicationTitle | Journal of international medical research |
PublicationTitleAlternate | J Int Med Res |
PublicationYear | 2014 |
Publisher | SAGE Publications |
Publisher_xml | – name: SAGE Publications |
References | Smits, Kummer, Hinrichs 2012; 35 Jemal, Bray, Center 2011; 61 Dela Cruz, Tanoue, Matthay 2011; 32 Wu, Gow, Yu 2008; 32 Froudarakis 2012; 83 Lynch 1993; 103 Wu, Yu, Tsai 2013; 41 Jung, Kim, Lee 2011; 2 Morgensztern, Waqar, Subramanian 2012; 7 Sakurada, Lara-Guerra, Liu 2008; 3 Sahn 1990; 41 Ruppert, Wislez, Poulot 2011; 28 Mok, Wu, Zhang 2009; 8 Gridelli, De Marinis, Di Maio 2011; 72 Heffner, Klein 2008; 83 Rami-Porta, Crowley, Goldstraw 2009; 15 Yang, Wu, Chan 2014; 83 Chiu, Shih, Tsai 2007; 57 Hirsch, Jänne, Eberhardt 2013; 8 Chen, Zhong, Zhang 2012; 17 Buccheri, Ferrigno, Tamburini 1996; 32A Imielinski, Berger, Hammerman 2012; 150 Jänne, Engelman, Johnson 2005; 23 Han, Eom, Kim 2011; 12 Mok 2011; 8 Barlési, Tchouhadjian, Doddoli 2005; 92 Li, Shi, Liang 2008; 60 Wen, Fu, Zhang 2011; 24 bibr1-0300060514539273 bibr19-0300060514539273 bibr14-0300060514539273 Rami-Porta R (bibr28-0300060514539273) 2009; 15 bibr23-0300060514539273 bibr5-0300060514539273 bibr27-0300060514539273 bibr10-0300060514539273 bibr2-0300060514539273 bibr7-0300060514539273 bibr15-0300060514539273 bibr6-0300060514539273 bibr11-0300060514539273 bibr24-0300060514539273 bibr12-0300060514539273 bibr8-0300060514539273 bibr20-0300060514539273 bibr17-0300060514539273 bibr16-0300060514539273 bibr9-0300060514539273 bibr21-0300060514539273 bibr3-0300060514539273 bibr25-0300060514539273 bibr18-0300060514539273 bibr13-0300060514539273 Mok T (bibr4-0300060514539273) 2009; 8 bibr22-0300060514539273 bibr26-0300060514539273 |
References_xml | – volume: 35 start-page: 189 year: 2012 end-page: 196 article-title: EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma publication-title: Cell Oncol (Dordr) contributor: fullname: Hinrichs – volume: 17 start-page: 978 year: 2012 end-page: 985 article-title: EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas publication-title: Oncologist contributor: fullname: Zhang – volume: 60 start-page: 183 year: 2008 end-page: 192 article-title: Prognostic significance of pleural lavage cytology in patients with lung cancer: a meta-analysis publication-title: Lung Cancer contributor: fullname: Liang – volume: 92 start-page: 13 year: 2005 end-page: 14 article-title: CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy publication-title: Br J Cancer contributor: fullname: Doddoli – volume: 57 start-page: 213 year: 2007 end-page: 221 article-title: Serum tumor markers as predictors for survival in advanced non-small cell lung cancer patients treated with gefitinib publication-title: Lung Cancer contributor: fullname: Tsai – volume: 41 start-page: 1409 year: 2013 end-page: 1418 article-title: Survival of lung adenocarcinoma patients with malignant pleural effusion publication-title: Eur Respir J contributor: fullname: Tsai – volume: 7 start-page: 1485 year: 2012 end-page: 1489 article-title: Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer publication-title: J Thorac Oncol contributor: fullname: Subramanian – volume: 72 start-page: 3 year: 2011 end-page: 8 article-title: Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues publication-title: Lung Cancer contributor: fullname: Di Maio – volume: 8 start-page: 661 year: 2011 end-page: 668 article-title: Personalized medicine in lung cancer: what we need to know publication-title: Nat Rev Clin Oncol contributor: fullname: Mok – volume: 103 start-page: 385S year: 1993 end-page: 389S article-title: Management of malignant pleural effusions publication-title: Chest contributor: fullname: Lynch – volume: 8 start-page: 227 year: 2009 end-page: 231 article-title: A small step towards personalized medicine for non-small cell lung cancer publication-title: Discov Med contributor: fullname: Zhang – volume: 32A start-page: 1135 year: 1996 end-page: 1141 article-title: Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution publication-title: Eur J Cancer contributor: fullname: Tamburini – volume: 12 start-page: 380 year: 2011 end-page: 386 article-title: EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases publication-title: Clin Lung Cancer contributor: fullname: Kim – volume: 41 start-page: 7 year: 1990 end-page: 13 article-title: The pathophysiology of pleural effusions publication-title: Annu Rev Med contributor: fullname: Sahn – volume: 23 start-page: 3227 year: 2005 end-page: 3234 article-title: Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology publication-title: J Clin Oncol contributor: fullname: Johnson – volume: 28 start-page: 565 year: 2011 end-page: 577 article-title: A simple view on lung cancer biology: the EGFR pathway publication-title: Rev Mal Respir contributor: fullname: Poulot – volume: 32 start-page: 605 year: 2011 end-page: 644 article-title: Lung cancer: epidemiology, etiology, and prevention publication-title: Clin Chest Med contributor: fullname: Matthay – volume: 83 start-page: 235 year: 2008 end-page: 250 article-title: Recent advances in the diagnosis and management of malignant pleural effusions publication-title: Mayo Clin Proc contributor: fullname: Klein – volume: 61 start-page: 69 year: 2011 end-page: 90 article-title: Global cancer statistics publication-title: CA Cancer J Clin contributor: fullname: Center – volume: 83 start-page: 367 year: 2012 end-page: 376 article-title: Pleural effusion in lung cancer: more questions than answers publication-title: Respiration contributor: fullname: Froudarakis – volume: 8 start-page: 373 year: 2013 end-page: 384 article-title: Epidermal growth factor receptor inhibition in lung cancer: status 2012 publication-title: J Thorac Oncol contributor: fullname: Eberhardt – volume: 150 start-page: 1107 year: 2012 end-page: 1120 article-title: Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing publication-title: Cell contributor: fullname: Hammerman – volume: 3 start-page: 527 year: 2008 end-page: 529 article-title: Tissue heterogeneity of EGFR mutation in lung adenocarcinoma publication-title: J Thorac Oncol contributor: fullname: Liu – volume: 15 start-page: 4 year: 2009 end-page: 9 article-title: The revised TNM staging system for lung cancer publication-title: Ann Thorac Cardiovasc Surg contributor: fullname: Goldstraw – volume: 24 start-page: 932 year: 2011 end-page: 943 article-title: Genetic and epigenetic changes in lung carcinoma and their clinical implications publication-title: Mod Pathol contributor: fullname: Zhang – volume: 2 start-page: 685 year: 2011 end-page: 693 article-title: Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib publication-title: Exp Ther Med contributor: fullname: Lee – volume: 83 start-page: 174 year: 2014 end-page: 181 article-title: Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS) publication-title: Lung Cancer contributor: fullname: Chan – volume: 32 start-page: 924 year: 2008 end-page: 930 article-title: Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma publication-title: Eur Respir J contributor: fullname: Yu – ident: bibr20-0300060514539273 doi: 10.1146/annurev.me.41.020190.000255 – ident: bibr8-0300060514539273 doi: 10.1016/j.rmr.2011.03.005 – ident: bibr15-0300060514539273 doi: 10.1016/j.cell.2012.08.029 – ident: bibr23-0300060514539273 doi: 10.1183/09031936.00069812 – volume: 8 start-page: 227 year: 2009 ident: bibr4-0300060514539273 publication-title: Discov Med contributor: fullname: Mok T – ident: bibr19-0300060514539273 doi: 10.1016/j.lungcan.2007.09.024 – ident: bibr22-0300060514539273 doi: 10.1183/09031936.00167407 – ident: bibr18-0300060514539273 doi: 10.1634/theoncologist.2011-0385 – ident: bibr21-0300060514539273 doi: 10.1378/chest.103.4_Supplement.385S – ident: bibr3-0300060514539273 doi: 10.1097/JTO.0b013e31827ed0ff – ident: bibr26-0300060514539273 doi: 10.1016/j.cllc.2011.02.006 – ident: bibr14-0300060514539273 doi: 10.1016/j.lungcan.2013.11.021 – ident: bibr1-0300060514539273 doi: 10.1016/j.ccm.2011.09.001 – ident: bibr9-0300060514539273 doi: 10.1097/JTO.0b013e318267223a – volume: 15 start-page: 4 year: 2009 ident: bibr28-0300060514539273 publication-title: Ann Thorac Cardiovasc Surg contributor: fullname: Rami-Porta R – ident: bibr6-0300060514539273 doi: 10.1038/nrclinonc.2011.126 – ident: bibr17-0300060514539273 doi: 10.1097/JTO.0b013e318168be93 – ident: bibr10-0300060514539273 doi: 10.1016/S0025-6196(11)60848-3 – ident: bibr5-0300060514539273 doi: 10.1016/j.lungcan.2010.12.009 – ident: bibr13-0300060514539273 doi: 10.1038/sj.bjc.6602296 – ident: bibr16-0300060514539273 doi: 10.1038/modpathol.2011.46 – ident: bibr12-0300060514539273 doi: 10.1016/j.lungcan.2007.02.016 – ident: bibr25-0300060514539273 doi: 10.1159/000338169 – ident: bibr27-0300060514539273 doi: 10.1016/0959-8049(95)00664-8 – ident: bibr7-0300060514539273 doi: 10.1200/JCO.2005.09.985 – ident: bibr24-0300060514539273 doi: 10.1007/s13402-012-0078-4 – ident: bibr2-0300060514539273 doi: 10.3322/caac.20107 – ident: bibr11-0300060514539273 doi: 10.3892/etm.2011.273 |
SSID | ssj0042652 |
Score | 2.207465 |
Snippet | Objective
A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor... A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor... Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor... OBJECTIVEA retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor... |
SourceID | proquest crossref pubmed sage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1110 |
SubjectTerms | Adenocarcinoma - genetics Adenocarcinoma - pathology Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - pathology DNA Mutational Analysis Female Follow-Up Studies Humans Lung Neoplasms - genetics Lung Neoplasms - pathology Male Middle Aged Mutation - genetics Neoplasm Staging Pleural Effusion, Malignant - genetics Pleural Effusion, Malignant - pathology Polymerase Chain Reaction Prognosis Receptor, Epidermal Growth Factor - genetics Retrospective Studies |
Title | Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation |
URI | https://journals.sagepub.com/doi/full/10.1177/0300060514539273 https://www.ncbi.nlm.nih.gov/pubmed/25239875 https://search.proquest.com/docview/1563994070 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBbp5tJL6bvbpGEKZaEQN7ZlSeteSgjrpoWWEDY0NyPLUgjE3uBdH_xT8m8zs7K7bEOgFx-MkYxnPPPNQ98w9imNtIykNYFNpA0SDDGCNJkWgabR0U5aGTo6O_zrtzy9SH5eissdVg9nYfovuPxCbVX4RmtjTX83ZaOP-iLjEWomEYmgsxfo3xX_1q6q3Ge7h6EadIfK021FlW1D_ZBdMJxue8J2YzWVYsR2j7PzP_PBdqO7En3dgcaxhGJT2Hyw57Yje4BOtzrD1s4qe86e9SgTjr1avGA7tn7JJmeepro7hPnm1NXyECZwtiGw7l6xu6zxDdYdLBzMvmfnULW-ZL-E6xpu0ECARoOFfrAx1_Wi0kD5XKgQ1F9RZw3c3lji8wDrXEv5uK_wY9O6Tqsa0rYGPAcUKQr0hAFtA429oqFitoSi297-NbvIZvOT06Af4RAYztUqiMoiMmlUomGJHZqKVBbC8JiX2saIdHhKfP4RLzDo4zItEL4aF5qo5NJZVZZT_oaN6kVt3zHQiS2UEhg4C56o2GqXOAy_dKKIZUCWY_Z5kEd-65k68mggM_9HdmP2cRBYjr8T1Uh0bRftMseVELJhlBuO2Vsvyb-rxYLIEpUYswmJNh909dFt3v_vg3vsKQKxxDcJ7rPRqmntBwQ7q-Kg19CDdbIAr7MsvAc_QvqA |
link.rule.ids | 315,783,787,867,21977,21978,27865,27936,27937,44957,45066,45345,45454 |
linkProvider | SAGE Publications |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9NADLZG9zBeELABhQFGmiohLajJ_ciytwktdGObpqkTe4suyR2atKZT2jz0T-G_xe4lK2VC4i0PkS-Kz_bns-8zwF4SGh1qWwRWahtISjGCRB7kgeHR0U5bPXR8d_j8Qo-u5emNuvlj1Ff7B2dfuK2KvmjprB-sm5mSxJJDhOK8otAeiyewSU9S9WDzKL36Me7cMEUe1ZYQeLLKUK1qlI9krMekR0BzrclrGXfS5_CsBYx45DX8AjZs9RIGl55xerGP49UFqtk-DvByxUW92IZfae17pRc4dXj8Lb3CSeOr7zO8rfCObB0N-R4KaXVxW00nBvloFieEz39ykwze31mm5kDrXMNHa4d4supCZ6kFb5waPZ0T6xzbu_9NjbUfdW9LzBfry-_AdXo8_joK2mkMQSFEPA_CMg-LJCzJR0SOrD7RuSpEJEpjIwItImFq_lDklL8JneSERAs3LMJSaGfjsjwQr6BXTSv7BtBIm8exohyYNBdH1jjpKJMyMmbCAF324XOnj-zek25kYcdL_pfu-vCpU1hGlsHlDlPZaTPLSBKhL0pYh3147TX5IC1SzHsYqz4MWLVZt-3-uczb_33xI2yNxudn2dnJxfd38JTwlfS9f7vQm9eNfU8YZp5_aHfrb7585hE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9xADBZtAqWXkj6zfapQFgpxs_Y8HPcW2rhJH2EJG5qbGXtmSiDrXbzrw_6U_NtKGbvLNhR6N7KxRtKnkfQJ4F0WGx1rV0VOahdJSjGiTB6UkeHV0V47PfI8O_zjVB-fy68X6qLrzeFZmO4PLj5wWxV90Y2zZuueW7_f1Rj36WAyjwjFekXhPRV3YVsS0Kfca_swP_s56V0xRR_VlRF4u8pIreuUt2RsxqVbYHOj0esm9uQ78KADjXgYtPwQ7rj6EQzHgXV6tYeT9RDVYg-HOF7zUa8ew3XehH7pFc48Hn3Jz3Dahgr8Ai9rvCJ7R0P-h8JaU13Ws6lBvp7FKWH0X9wog_Mrx_Qc6Lxv-XrtI56sO9FZasWHp8FA6cR6x27-v22wCevuncVytfn6J3CeH00-HUfdRoaoEiJdRrEt4yqLLfmJxJPlZ7pUlUiENS4h4CIypuePRUk5nNBZSWi08qMqtkJ7l1p7IJ7CVj2r3S6gka5MU0V5sBIyTZzx0lM2ZWTKpAHaDuB9r49iHog3irjnJv9LdwN42yusIOvgkoep3axdFCSJEBglraMBPAua_CMtUcx9mKoBDFm1RX_0_vma5__74Bu4N_6cF99PTr-9gPsEsWRo_3sJW8umda8IxizL191h_Q1aZecq |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Frequency+of+EGFR+mutations+in+lung+adenocarcinoma+with+malignant+pleural+effusion%3A+Implication+of+cancer+biological+behaviour+regulated+by+EGFR+mutation&rft.jtitle=Journal+of+international+medical+research&rft.au=Zou%2C+JianYong&rft.au=Bella%2C+Amos+Ela&rft.au=Chen%2C+ZhenGuang&rft.au=Han%2C+XiangQian&rft.date=2014-10-01&rft.eissn=1473-2300&rft.volume=42&rft.issue=5&rft.spage=1110&rft_id=info:doi/10.1177%2F0300060514539273&rft_id=info%3Apmid%2F25239875&rft.externalDocID=25239875 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0605&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0605&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0605&client=summon |